Structure |
Chemical Name |
CAS |
MF |
 |
EMtricitabine iMpurity A |
|
|
 |
RocuroniuMbroMide iMpurity D |
|
|
 |
(3S,4R)-4-(4-Fluorophenyl)piperidine-3-Methanol Hydrochloride |
220548-73-2 |
C12H17ClFNO |
 |
LaMotrigine IMpurity D |
661463-79-2 |
C9H5Cl2N3O2 |
 |
デメチルピペラジニルデスエチルシルデナフィルスルホニルクロリド |
139756-27-7 |
C15H15ClN4O4S |
 |
Rizatriptan IMpurity B |
1016900-28-9 |
C13H15ClN5 |
 |
rac Adrenaline IMpurity D |
1095714-91-2 |
C16H19NO3 |
 |
2-イソプロペニル-6-イソプロピルフェノール |
74926-89-9 |
C12H16O |
 |
Irinotecan IMpurity G |
947687-02-7 |
C35H42N4O6 |
 |
ジヒドロキシベンダムスチン |
109882-30-6 |
C16H23N3O4 |
![5-Chloro-6'-Methyl-3-[4-(Methylsulfonyl)phenyl]-2,3'-bipyridine 1'-Oxide](/CAS/GIF/325855-74-1.gif) |
5-Chloro-6'-Methyl-3-[4-(Methylsulfonyl)phenyl]-2,3'-bipyridine 1'-Oxide |
325855-74-1 |
C18H15ClN2O3S |
 |
Lafutidine IMpuritiy B |
174583-84-7 |
C22H29N3O5S |
 |
N,N-ジメシル-2-フェノキシアニリン |
905858-63-1 |
C14H15NO5S2 |
 |
4,5-Dihydro-α,3-diMethyl-5-oxo-1-phenyl-α-sulfo-1H-pyrazole-4-acetic Acid |
1357477-99-6 |
C13H14N2O6S |
 |
tert-butyl 4-(2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)Methyl)benzoyl)piperazine-1-carboxylate |
763114-04-1 |
C25H27FN4O4 |
![1H-IMidazole, 4-Methyl-1-[3-nitro-5-(trifluoroMethyl)phenyl]-](/CAS/GIF/916975-92-3.gif) |
1H-IMidazole, 4-Methyl-1-[3-nitro-5-(trifluoroMethyl)phenyl]- |
916975-92-3 |
C11H8F3N3O2 |
 |
2-(3-メチル-5-オキソ-1-フェニル-4,5-ジヒドロ-1H-ピラゾール-4-イル)プロパン-2-スルホン酸 |
1323485-71-7 |
C13H16N2O4S |
 |
Ondansetron Impurity B |
|
|
![3-Pyrrolidinepropanoic acid, α-[[(1,1-dimethylethoxy)carbonyl]amino]-2-oxo-, (αS,3S)-](/CAS/20211123/GIF/741267-75-4.gif) |
3-Pyrrolidinepropanoic acid, α-[[(1,1-dimethylethoxy)carbonyl]amino]-2-oxo-, (αS,3S)- |
741267-75-4 |
C12H20N2O5 |
 |
Topiroxostat Impurity 44 |
1824131-48-7 |
C7H6N4O |
 |
Fexofenadine Impurity 12 |
1010812-98-2 |
C32H37NO4 |
 |
2,2'-(oxybis((2-chloro-5-iodophenyl)methylene))diphenol |
|
C26H18Cl2I2O3 |
 |
Gliclazide Impurity 6 |
1207714-41-7 |
C8H10N2O3S |
 |
Phenol, 4,4'-(4-pyridinylmethylene)bis- |
109810-81-3 |
C18H15NO2 |
 |
Ropivacaine Impurity 50 |
|
|
![Glycine, N-[(4,7-dihydroxy-1-methyl-3-isoquinolinyl)carbonyl]-](/CAS/20210111/GIF/2173338-12-8.gif) |
Glycine, N-[(4,7-dihydroxy-1-methyl-3-isoquinolinyl)carbonyl]- |
2173338-12-8 |
C13H12N2O5 |
![5-Thiazolecarboxylic acid, 2-[3,5-diformyl-4-(2-methylpropoxy)phenyl]-4-methyl-, ethyl ester](/CAS/20200611/GIF/2375033-26-2.gif) |
5-Thiazolecarboxylic acid, 2-[3,5-diformyl-4-(2-methylpropoxy)phenyl]-4-methyl-, ethyl ester |
2375033-26-2 |
C19H21NO5S |
 |
Furosemide Impurity 6 |
74793-12-7 |
C12H10ClNO3 |
 |
Lumateperone Impurity 3 |
313544-76-2 |
C17H21N3O3 |
 |
LeflunoMide EP IMpurity F |
1403564-06-6 |
C12H9F3N2O2 |
![4'-((1,7'-dimethyl-2'-propyl-1H,1'H-2,5'-bibenzo[d]imidazol-1'-yl)methyl)biphenyl-2-carboxylic acid](/) |
4'-((1,7'-dimethyl-2'-propyl-1H,1'H-2,5'-bibenzo[d]imidazol-1'-yl)methyl)biphenyl-2-carboxylic acid |
|
|
 |
Itraconazole iMpurity D |
|
|
 |
3-amino-2-chloroacrolein |
221615-73-2 |
C3H4ClNO |
 |
3-アミノ-4-ピラゾールカルボニトリル |
16617-46-2 |
C4H4N4 |
 |
BenzaMide, 3,4-bis(cyclopropylMethoxy)-N-(3,5-dichloro-4-pyridinyl)- |
1391052-24-6 |
C20H20Cl2N2O3 |
 |
1-(4-アセチルフェニル)-2-メチル-1-プロパノン |
103931-20-0 |
C12H14O2 |
 |
ButanaMide, 4-hydroxy-N-(1-Methylethyl)- |
42042-66-0 |
C7H15NO2 |
![5H-chroMeno[2,3-b]pyridin-7-ylacetic acid](/CAS/GIF/52549-07-2.gif) |
5H-chroMeno[2,3-b]pyridin-7-ylacetic acid |
52549-07-2 |
C14H11NO3 |
![IMp. B (EP): (2RS,4S)-2-[[[[3-(2-Chloro-6-fluorophenyl)-5-Methylisoxazol-4-yl]carbonyl]aMino]Methyl]-5,5-diMethyl- thiazolidine-4-carboxylic Acid (Penilloic Acids of Flucloxacillin)](/) |
IMp. B (EP): (2RS,4S)-2-[[[[3-(2-Chloro-6-fluorophenyl)-5-Methylisoxazol-4-yl]carbonyl]aMino]Methyl]-5,5-diMethyl- thiazolidine-4-carboxylic Acid (Penilloic Acids of Flucloxacillin) |
|
|
![IMp. C (EP): (4-(DiphenylMethyl)-1,1-bis[(E)-3-phenylprop-2-enyl]piperaziniuM Chloride](/CAS/20211123/GIF/95062-18-3.gif) |
IMp. C (EP): (4-(DiphenylMethyl)-1,1-bis[(E)-3-phenylprop-2-enyl]piperaziniuM Chloride |
95062-18-3 |
C35H35ClF2N2 |
 |
IMp. E (EP): 4-AMino-5-(ethylsulphonyl)-2-Methoxybenzoic Acid |
|
|
 |
1-ニトロ-3,7-ジメチルアダマンタン |
6588-68-7 |
C12H19NO2 |
 |
6-O-Benzyl-4-dehydroxy-4-diMethylphenylsilyl Entecavir |
649761-24-0 |
C27H31N5O2Si |
 |
Desisobutyl-n-butyl BortezoMib |
1104011-35-9 |
C19H25BN4O4 |
 |
2-aMino-4-Methoxy-5-(3-Morpholinopropoxy)benzaMide |
246512-44-7 |
C15H23N3O4 |
 |
N-(4,6-dichloro-2-(propylthio)pyriMidin-5-yl)forMaMide |
1402150-28-0 |
C8H9Cl2N3OS |
 |
Ebastine IMpurity G |
1429071-65-7 |
C32H39NO3 |
 |
((R)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxaMido)propanaMido)butyl)boronic acid |
1132709-15-9 |
C19H25BN4O4 |
![N-[(1S)-2-アミノ-2-オキソ-1-(フェニルメチル)エチル]-2-ピラジンカルボキサミド](/CAS/GIF/289472-80-6.gif) |
N-[(1S)-2-アミノ-2-オキソ-1-(フェニルメチル)エチル]-2-ピラジンカルボキサミド |
289472-80-6 |
C14H14N4O2 |
 |
(3aS,4R,6S,6aR)-6-AMinotetrahydro-2,2-diMethyl-4H-cyclopenta-1,3-dioxol-4-ol |
592533-90-9 |
C8H15NO3 |
![(1R,2R,3S,5R)-3-(7-((1S,2R)-2-(3,4-difluorophenyl)cyclopropylaMino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol](/CAS/20150408/GIF/CB62664138.gif) |
(1R,2R,3S,5R)-3-(7-((1S,2R)-2-(3,4-difluorophenyl)cyclopropylaMino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
2096989-55-6 |
C23H28F2N6O4S |
 |
Rivaroxaban iMpurity |
1616563-62-2 |
C15H17N3O5 |
 |
cefoxitin iMpurity D |
|
|
 |
3-Morpholinone, 4-(2,4-diaMinophenyl)- |
482308-13-4 |
C10H13N3O2 |
 |
PANTOPRAZOLE SULFONE N-OXIDE |
953787-55-8 |
C16H15F2N3O6S |
 |
(R)-5-(aminomethyl)-2-((R)-carboxy((Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido)methyl)-3,6-dihydro-2H-1,3-thiazine-4-carboxylic acid |
|
|
 |
Isavuconazole Impurity 44 |
|
|
 |
Butanoic acid, L-2-aminobutanoyl-L-2-amino-, methyl ester (9CI) |
772292-30-5 |
C9H18N2O3 |
 |
Hexanoic acid, 3-(hydroxymethyl)-, (3R)- |
2096999-79-8 |
C7H14O3 |
 |
2-(((Z)-(1-(2-aminothiazol-4-yl)-2-(((2S,3S)-1-(ethoxysulfonyl)-2-methyl-4-oxoazetidin-3-yl)amino)-2-oxoethylidene)amino)oxy)-2-methylpropanoic acid |
|
|
 |
3-Thiophenecarboxylic acid, 4-formyl-2,5-dihydro-2-(4-hydroxybutylidene)-5-methyl-, (2Z)- |
1025974-23-5 |
C11H14O4S |
![1H-Pyrrole-3-methanamine, 1-[(1,4-dihydro-3-pyridinyl)sulfonyl]-5-(2-fluorophenyl)-N-methyl-](/CAS/20200611/GIF/2416241-98-8.gif) |
1H-Pyrrole-3-methanamine, 1-[(1,4-dihydro-3-pyridinyl)sulfonyl]-5-(2-fluorophenyl)-N-methyl- |
2416241-98-8 |
C17H18FN3O2S |
 |
impurity 44 |
|
|
 |
3-((2-acetamido-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy)propane- 1,2-diyl diacetate |
96429-68-4 |
|
 |
L-erythro-Pentonic acid, 2-deoxy-2-fluoro-2-methyl-, γ-lactone, 3,5-dibenzoate, (2S)- |
1946820-91-2 |
C20H17FO6 |
![5,5'-Bi-1H-benzimidazole, 6,6'-bis(difluoromethoxy)-2,2'-bis[[(3,4-dimethoxy-2-pyridinyl)methyl]thio]-](/CAS/20200611/GIF/2251784-93-5.gif) |
5,5'-Bi-1H-benzimidazole, 6,6'-bis(difluoromethoxy)-2,2'-bis[[(3,4-dimethoxy-2-pyridinyl)methyl]thio]- |
2251784-93-5 |
C32H28F4N6O6S2 |
![1,4,7,10-Tetraazacyclododecane-1,7-diacetic acid, 4,10-bis[2,3-dihydroxy-1-(hydroxymethyl)propyl]-](/CAS/20200611/GIF/2514736-58-2.gif) |
1,4,7,10-Tetraazacyclododecane-1,7-diacetic acid, 4,10-bis[2,3-dihydroxy-1-(hydroxymethyl)propyl]- |
2514736-58-2 |
C20H40N4O10 |
 |
Valsartan Methyl Ester N2-Trityl Analog |
883223-10-7 |
C44H45N5O3 |
 |
Ampicillin Impurity G |
|
|
 |
N-(5-((diphenylphosphoryl)methyl)-4-(3-fluorophenyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide |
|
|
 |
Budesonide Impurity 28 |
|
|
![Ethanol, 2-[2-(2-methyl-4-nitro-1H-imidazol-1-yl)ethoxy]-](/CAS/20210111/GIF/19765-12-9.gif) |
Ethanol, 2-[2-(2-methyl-4-nitro-1H-imidazol-1-yl)ethoxy]- |
19765-12-9 |
C8H13N3O4 |
 |
INDEX NAME NOT YET ASSIGNED |
2452301-30-1 |
C23H27ClO7 |
![(5R,6S)-6-((R)-1-hydroxyethyl)-7-oxo-3-((S)-tetrahydrofuran-2-yl)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid 4,4-dioxide](/) |
(5R,6S)-6-((R)-1-hydroxyethyl)-7-oxo-3-((S)-tetrahydrofuran-2-yl)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid 4,4-dioxide |
|
|
 |
(3S,5R,6E) Rosuvastatin Calcium Salt (2:1) |
2414245-11-5 |
C22H30CaFN3O6S |
 |
INDEX NAME NOT YET ASSIGNED |
2452301-42-5 |
C23H27ClO7 |
 |
2'-アミノ-2-フルオロベンゾフェノン |
1581-13-1 |
C13H10FNO |
 |
(R)-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2,2-dimethyl-1,2,3,4-tetrahydroisoquinolin-2-ium |
2480467-84-1 |
C28H35NO7S |
 |
2-アミノ-4-メチル-6-(3-ピリジル)ピリミジン |
90916-52-2 |
C10H10N4 |
 |
1-ベンジル-4-(5,6-ジメトキシ-1-オキソインダン-2-Yリンデンメチル)ピペリジン |
120014-07-5 |
C24H27NO3 |
 |
Crisaborole Impurity 16 |
2268785-42-6 |
C14H10BNO3 |
 |
グアニジン |
113-00-8 |
CH5N3 |
 |
(3R,5S)-フルバスタチンTERT-ブチルエステル |
194934-96-8 |
C28H34FNO4 |
 |
Brivaracetam Impurity 55 |
|
|
![α-(4-クロロフェニル)-α-[2-(ジメチルアミノ)エチル]-2-ピリジンアセトニトリル](/CAS/GIF/65676-21-3.gif) |
α-(4-クロロフェニル)-α-[2-(ジメチルアミノ)エチル]-2-ピリジンアセトニトリル |
65676-21-3 |
C17H18ClN3 |
 |
Baloxavir Impurity ABCDEFGHJKL |
|
|
 |
INDEX NAME NOT YET ASSIGNED |
2514724-36-6 |
C22H19F2N3 |
 |
スコポリン |
487-27-4 |
C8H13NO2 |
![N-[1-(1-ベンジル-2-フェニルエチル)-4-ピペリジニル]-N-フェニルプロパンアミド](/CAS/GIF/1474-02-8.gif) |
N-[1-(1-ベンジル-2-フェニルエチル)-4-ピペリジニル]-N-フェニルプロパンアミド |
1474-02-8 |
C21H26N2O |
 |
Oseltamivir Impurity 106 |
|
|
 |
Oseltamivir Impurity 85 |
|
|
 |
Oseltamivir Impurity 83 |
|
|
 |
Oseltamivir Impurity 75 |
|
|
![1,1'-ビ[シクロヘキサン]-1-カルボン酸](/CAS/GIF/60263-54-9.gif) |
1,1'-ビ[シクロヘキサン]-1-カルボン酸 |
60263-54-9 |
C13H22O2 |
 |
Dapagliflozin Impurity 49 |
|
|
![6,11-ジヒドロ-11-[3-(ジメチルアミノ)プロピル]ジベンゾ[b,e]オキセピン-11-オール](/CAS/GIF/4504-88-5.gif) |
6,11-ジヒドロ-11-[3-(ジメチルアミノ)プロピル]ジベンゾ[b,e]オキセピン-11-オール |
4504-88-5 |
C19H23NO2 |
 |
1-(2-クロロエチル)-3-(ジシクロプロピルメチル)尿素 |
54187-03-0 |
C10H17ClN2O |
 |
3-ヒドロキシ-2,4-ジメトキシベンズアルデヒド |
32246-34-7 |
C9H10O4 |
 |
3-(アミノスルホニル)-5-(ブチルアミノ)-4-フェノキシ安息香酸ブチル |
32643-00-8 |
C21H28N2O5S |
 |
11β,16α,17α,21-テトラヒドロキシプレグナ-4-エン-3,20-ジオン |
1171-81-9 |
C21H30O6 |